🟢 Painreform is trading 5.5% up in pre-market; catalyst remains unverified

Painreform is trading at $0.93, 5.5% up in pre-market; the reason for the move remains unverified.

• The stock closed at $0.88 on October 6 after several declining sessions; searches did not identify a company announcement dated October 7 explaining the gain.
• The latest surfaced company update was dated September 9.
• The broader pre-market backdrop was softer, and available evidence does not establish a company-specific, sector or market catalyst.